Fundraising Fox

Vogenx

Raleigh, US · Founded 2021 · Delaware corporation

Biotech

Founders & leadership

WW
William WilkisonExecutive
SD
Steven DelmarinExecutive
JG
James GreeninExecutive

Board

PP
Pete PieracciniBoard director
RG
Richard GormanBoard director
TB
Tim BorisBoard director

Reported raises · per SEC filings

Form D private placements

$750K disclosed across 1 round · 2025

▶$750KraisedJan 2026 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • William WilkisonExecutive Officer, Director
  • Pete PieracciniDirector
  • Steven DelmarExecutive Officer, Director
  • Richard GormanDirector
  • Tim BorisDirector
  • James GreenExecutive Officer, Director
Offering amount
$5M
Amount sold
$750K
First sale
Dec 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Vogenx IPO Raises $81M for Trial in Metabolic Disease With No Approved Drugs - MedCity Newsmedcitynews.com · Aug 2026Funding Roundup: Braveheart, Attovia, Vogenx All Announce IPO’s | PharmExecpharmexec.com · Aug 2026Vogenx raises $81M in IPOaxios.com · Aug 2026Vogenx prices IPO at $13 per share, raising $81.3M By Investing.cominvesting.com · Aug 2026Ratio collects $70M for its radiopharmaceutical trials; Vogenx plans $67M IPOendpoints.news · Jul 2026VOGX IPO News - Metabolic disorders biotech Vogenx sets terms for $75 million IPOrenaissancecapital.com · Jul 2026

Frequently asked questions

How much funding has Vogenx raised?
Vogenx has disclosed $750K raised across 1 round.
Where is Vogenx headquartered?
Vogenx is headquartered in Raleigh, US.